Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease

Yao Chen1,2, Yumeng Gan1,2, Huijie Zhong1,2

  • 1Department of Infectious Disease and Hepatic Disease, First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.

Frontiers in Microbiology
|December 21, 2023
PubMed

Insights

Gut microbes translocating to the liver activate hepatic macrophages, driving the progression of non-alcoholic fatty liver disease (NAFLD). This review explores microbial translocation and its impact on liver inflammation and NAFLD.

Area of Science:

  • Hepatology
  • Immunology
  • Microbiology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition with potential severe outcomes.
  • Hepatic macrophages, particularly Kupffer cells, are critical in NAFLD pathogenesis.
  • The gut microbiome's role in modulating immune responses, including in the liver, is increasingly recognized.

Purpose of the Study:

  • To review evidence on intestinal microbial translocation into the liver.
  • To examine the impact of translocated microbes on hepatic macrophage polarization.
  • To summarize mechanisms linking microbial translocation to NAFLD progression.

Main Methods:

  • Literature review of recent studies on microbial translocation and NAFLD.
  • Analysis of cellular and molecular signaling pathways involved.
  • Synthesis of evidence on hepatic macrophage activation by gut microbes.

Main Results:

  • Gut microbes can penetrate the intestinal barrier and reach the liver.
  • Translocated microbes directly influence hepatic macrophage polarization.
  • Microbial translocation contributes to liver inflammation and NAFLD progression.

Conclusions:

  • Microbial translocation is a significant factor in NAFLD pathogenesis.
  • Understanding these mechanisms offers potential therapeutic targets for NAFLD.
  • Further research is needed to elucidate specific microbial and host pathways.